EUCTR2020-001720-33-IT进行中（未招募）1 期
Cyclosporine 0.1% Eye Drops as Prophylactic Treatment in Post Surgical Ocular Surface System Failure Within The Age - Cyclosporine Eye Drops in prophylactic treatment of Ocular Surface System Failure
IVERSITÀ CAMPUS BIO-MEDICO DI ROMA0 个研究点目标入组 100 人开始时间: 2021年2月10日最近更新:
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Inclusion criterion
- •Signature of informed consent and willingness to participate in the study for its entire duration
- •Cataract of degrees N2-3; C1-2 according to (Lens Opacity Classification System) LOCS
- •Post-menopausal women and men over the age of 18 for whom cataract surgery has been scheduled
- •Patient without previous inflammatory and / or autoimmune ocular and / or systemic pathologies
- •Patient without previous ocular surgery
- •Patient without previous or concomitant ocular pathologies
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 25
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 75
排除标准
- •Exclusion criteria
- •Patients under topical or systemic therapy with anti-inflammatory drugs
- •Presence of ocular or peri-ocular malignant or premalignant neoplasms
- •Active or suspected ocular or periocular infections
- •Complicated cataract
- •History of drug allergy under study
研究者
相似试验
已完成
早期 1 期
Cyclosporine 0.1% Eye Drops as Prophylactic Treatment In Cataract SurgeryOcular Surface DiseaseOcular InflammationNCT04812951Campus Bio-Medico University101
招募中
不适用
Treatment efficacy of 0.05% cyclosporine eyedrop on ocular surface changes after anti-glaucoma medication in glaucoma patients.Diseases of the eye and adnexaKCT0007124Keimyung University Dongsan Hospital30
已完成
3 期
Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic KeratoconjunctivitisAtopic ConjunctivitisNCT00884585Allergan176
已完成
4 期
Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD TreatmentGraft Versus Host Disease in EyeNCT05294666Peking University Third Hospital89
已完成
4 期
Efficacy of 0.05% Cyclosporin Eye Drop in Stevens Johnson Syndrome Patient With Chronic Dry EyeStevens-Johnson SyndromeNCT01488396Mahidol University31